HeraMED Ltd. (AU:HMD) has released an update.
HeraMED Ltd., a leader in digital maternity care, has recently undergone significant leadership changes, including the appointment of Anoushka Gungadin as CEO, and has penned strategic agreements in the US to develop maternity care solutions. With a growing user base that reached 3,168 and 79,938 total measurements by the end of Q1 FY24, HeraMED continues to solidify its data repository, which is instrumental in improving health outcomes. The company remains under voluntary suspension as it navigates through a business restructuring and secures financing for its operations.
For further insights into AU:HMD stock, check out TipRanks’ Stock Analysis page.
